Detalles de la búsqueda
1.
Continuity of care for patients with de novo metastatic cancer during the COVID-19 pandemic: A population-based observational study.
Int J Cancer
; 154(10): 1786-1793, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38268393
2.
The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Breast Cancer Res Treat
; 203(2): 339-349, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37878148
3.
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.
Breast Cancer Res Treat
; 205(2): 287-302, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381274
4.
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study.
Breast Cancer Res Treat
; 199(1): 81-89, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36892723
5.
Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.
Breast Cancer Res Treat
; 198(2): 239-251, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36635428
6.
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.
Breast Cancer Res Treat
; 192(2): 331-342, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025003
7.
Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.
Breast Cancer Res Treat
; 188(2): 571-581, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743103
8.
Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.
Oncology
; 93(5): 323-328, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28848182
9.
mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.
Int J Cancer
; 138(10): 2312-21, 2016 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26452336
10.
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.
Lancet
; 385(9980): 1843-52, 2015 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25862517
11.
A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer.
Eur Urol Oncol
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485614
12.
Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.
Clin Breast Cancer
; 24(2): 103-111, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38007349
13.
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
NPJ Breast Cancer
; 10(1): 4, 2024 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184611
14.
Quality of integrated female oncofertility care is suboptimal: A patient-reported measurement.
Cancer Med
; 12(3): 2691-2701, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031940
15.
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer: an observational study of the SONABRE Registry.
Lancet Reg Health Eur
; 26: 100573, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895447
16.
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.
N Engl J Med
; 360(6): 563-72, 2009 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-19196673
17.
Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.
BMC Cancer
; 12: 292, 2012 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-22804917
18.
Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium.
Eur J Cancer
; 160: 261-272, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799210
19.
Oxaliplatin infusion-related venous pain: prevention by simultaneous intravenous fluids.
BMJ Support Palliat Care
; 11(2): 226-229, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32451327
20.
High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue.
J Cell Mol Med
; 14(8): 2122-31, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19453520